A&J Science, an innovative biotech company based in South Korea and dedicated to addressing AMR, is advancing two distinct pre-clinical candidates for C. difficile infection (CDI) and non-tuberculous mycobacterial pulmonary disease (NTM-PD) indications into IND-enabling [...]
More news
Kinzbio’s mission is to harness the power of phages—nature's precision antimicrobials—to address some of the [...]
The BamA Inhibitor project (Justus-Liebig-University Giessen) has been awarded a prestigious €180k grant through the [...]
November 5th, 2024 – INCATE (the INCubator for Antibacterial Therapies in Europe) is pleased to [...]
© Marek Kruszewski Researchers from the Helmholtz Centre for Infection Research in Braunschweig [...]
credits: Interfinity On April 9th, 2025, 20:30, at Voltahalle Basel, the Interfinity Festival, [...]
Puray, together with Munich University of Applied Sciences, has been awarded a prestigious €300k grant [...]
Photo credits: Phiogen PHIOGEN, a Texas-based venture developing off-the-shelf live biotherapeutic products, is excited [...]
Photo credits: INCATE Cavenagh Health exists to foster innovation and support the creation of new [...]
